Grifols partners with Google Cloud to harness its powerful AI technologies to greatly accelerate development of new biopharma medicines
Grifols se alía con Google Cloud para aprovechar su potente tecnología de IA para acelerar el desarrollo de nuevos medicamentos biofarmacéuticos
Intel ID : 370557
Relevant Documents
| Press Release | 01 Aug 2023 | Grifols_Nota_de_Prensa_2023.pdf | ES |
|
| Intel ID | 370557 | |||
| Value | ND | |||
| Native Currency | Euro (EUR) | |||
|
Financial Data - Grifols
(31 Dec 2023) |
Revenue: EUR 7.077,97m EBITDA: EUR 1.247,56m Net Debt: EUR 10.541,45m |
|||
| Date |
 |
|||
| Country | |
|||
| Geography | |
|||
| Subsector (Old TTR Sectors) |
|
|||
| Primary Subsector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 40.03.06 Hosting, Data Storage & Processing (Primary) 40 Information Technology / 40.03 Internet, Software & IT Services |
|||
| Type |
 |
|||
| Intel Grade |
|
|||
| Source |
|
|||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
40.03.06 Hosting, Data Storage & Processing 40 Information Technology / 40.03 Internet, Software & IT Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.